Aug 2018

The 2018 Greater New York Dental Meeting (November 25 – 28, 2018)

PolyPid will present its product candidate D-PLEX intended to treat peri-implantitis,  in booth no. 413 at the Israeli pavilion, in the Greater New York Dental Meeting, to be held on November 25th - 28th 2018, in the Jacob K. Javits Convention Center, 11th Ave B/W 34th & 39th Street, David Intercontinental hotel, New York.

Aug 2018

The 39th SICOT Orthopedic World Congress (October 10-13, 2018)

PolyPid’s abstract “Enhanced bone healing of Gustilo III severe open tibia fractures treated by immediate antibiotic-formulated bone grafting” was accepted for Oral presentation at the 39th SICOT Orthopaedic World Congress, to be held in Montreal, Canada, from 10-13 October 2018. The Oral Free Paper will be presented by Dr. Noam Emanuel, PolyPid’s CTO, as a part of the Trauma Free Papers (Pelvis/Lower Limb) session, currently due to take place on 10/12/2018 at 16:00 - 17:30 in Room 517d.

Jul 2018

The 11th Meeting of the Israeli Chapter of the Controlled Release Society (ICRS), (October 7-9, 2018)

PolyPid’s abstract “PLEX technology - A lipid-and-polymer-based novel local drug delivery system - from concept to clinical practice” was accepted for Oral presentation at the 11th meeting of the ICRS, to be held on October 7-9, 2018, at the Hacienda Forest View Hotel, Ma'alot Tarshiha. The presentation is scheduled for Sunday, October 7, 2018 from 15:20 until 15:35  in the session entitled:  INNOVATIVE BIO-INSPIRED AND BIOMIMETIC MATERIALS.

May 2018

Israel’s 17th National Life Sciences & Technology Week (May 15 – 17, 2018)

PolyPid will participate at IATI BioMed (Biomed Israel 2018), Israel’s 17th National Life Sciences & technology Week, to be held May 15 - 17, 2018, at the Tel Aviv Convention Center, Israel. The company will be also presenting at the Start Up Pavilion by Israel Innovation Authority, on May 16 (Booth SP16).

Jan 2018

9th Global Drug Delivery & Formulation – DDF Summit (March 12-14 2018)

PolyPid will participate at the DDF Summit Meeting, to be held in Berlin, Germany.  PolyPid will be represented by Dr. Tamar Alon, PolyPid’s Chief Business Officer. PolyPid will be exploring new collaborations around its revolutionary PLEX™ localized, controlled and prolonged drug delivery platform and products.

Jan 2018

Drug Delivery Partnerships – DDP Meeting (January 22-24, 2018)

PolyPid will participate at the DDP meeting,  to be held in PGA National Resort & Spa, Palm Beach Gardens, FL, US. PolyPid’s poster entitled: “PLEX™ Revolutionizing Medicine by Enabling Localized Controlled and Prolonged Therapeutics” will be presented in the Poster Exhibit Hall. PolyPid will be represented by Dr. Tamar Alon, PolyPid’s Chief Business Officer. PolyPid will be exploring new collaborations around its core PLEX™ local drug delivery platform and products.

Dec 2017

J.P. Morgan 36th Annual Healthcare Conference (January 8 – 11, 2018)

PolyPid's senior management will attend the J.P. Morgan 36th Annual Healthcare Conference, to be held on January 8 - 11, 2018 in San Francisco, California, USA.

Oct 2017

The Innovations in Cardiovascular Interventions – ICI Meeting (December 3-5, 2017)

PolyPid will participate at the ICI meeting with its product candidate D-PLEX in the ICI Meeting, to be held in David Intercontinental hotel, Tel Aviv, Israel. PolyPid’s presentation titled: “D-PLEX™: Novel Solution for Prevention of surgical Site Infections” will be presented by Dr. Tamar Alon, PolyPid’s Chief Business Officer on Monday December 4th at 14:00 -15:30 section in Hall 7. The company will be also presenting at the ICI Innovation Award Competition.

Aug 2017

The 37th Annual Meeting of the Israel Orthopaedic Association (December 13-14, 2017)

PolyPid’s abstract “Enhanced bone healing of Gustilo III severe open tibia fractures treated by immediate antibiotic-formulated bone grafting” was accepted for Oral presentation at the 37th Annual Meeting of the Israel Orthopaedic Association, to be held in David Intercontinental, Tel Aviv, Israel, on December, 13-14 2017. Prof. Moshe Salai, Head Orthopedic Division, Tel Aviv Sourasky Medical Center, ISRAEL, will present in Hall B, on December 13th, at 9:00AM.

Jul 2017

The 7th Annual Partnership Opportunities in Drug Delivery (PODD) (October 19- 20, 2017)

Dr. Tamar Alon, PolyPid’s Chief Business Development Officer, will present at the Partnership Opportunities in Drug Delivery (PODD) meeting, to be held on October 19- 20, 2017 in Marriott Copley Place, Boston, MA, USA. Dr. Alon's presentation titled: “PLEX™ Local Drug Delivery Platform: Revolutionizing Medicine by Enabling Localized, Controlled and Prolonged Therapeutics” will take place in Track 1B on October 19th at 5:15 pm.

Technology

The PLEX™ (Polymer-Lipid Encapsulation matriX) platform is a matrix made of alternating layers of polymers and lipids that allows controlled, local release of unmodified drugs over extended periods of time.

Read More >

D-PLEX100

Provides safe and effective local antibiotic protection against SSI (surgical Site Infection) at the needed tissues or organs by administration during surgical procedures.

Read More >

D-PLEX1000

Comprised of antibiotic eluting ß tri-calcium phosphate (ßTCP) granules, designed for bone related infections applications.

Read More >